Insider trades
Stengone Carmine N.
Stengone Carmine N. made 0 buys and 4 sales on the open market in the last 12 months at Contineum Therapeutics, Inc. Each trade with the role, price and filing.
Insider trades
Where they report
| Company | Role | Holding after | Latest trade |
|---|---|---|---|
| Contineum Therapeutics, Inc. NASDAQ:CTNM | Director, CEO and President | 17,217 | Sep 8, 2026 |
Open-market trades, newest first
| Company | Date | Trade | Shares | Price | Value | Holding after | Filed |
|---|---|---|---|---|---|---|---|
| Contineum Therapeutics, Inc. NASDAQ:CTNM | Sep 8, 2026 | Sale | 2,500 | US$16.46 | US$41,150 | 17,217 | Sep 8, 2026 |
| Contineum Therapeutics, Inc. NASDAQ:CTNM | Aug 3, 2026 | Sale | 2,500 | US$16.01 | US$40,025 | 17,217 | Aug 3, 2026 |
| Contineum Therapeutics, Inc. NASDAQ:CTNM | Jul 8, 2026 | Sale | 2,500 | US$16.00 | US$40,000 | 17,217 | Jul 8, 2026 |
| Contineum Therapeutics, Inc. NASDAQ:CTNM | Jun 30, 2026 | Sale | 10,000 | US$16.01 | US$160K | 17,217 | Jul 1, 2026 |